An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology
作者: Emmanouil KalampokasFiona PayneAngheliki NomikosMahalakshmi Gurumurthy
作者单位: 1Department of Gynecologic Oncology, Aberdeen Royal Infirmary, United Kingdom
2Department of Pathology, Aberdeen Royal Infirmary, United Kingdom
3Department of Pathology, Western General Hospital, Crewe Road South, Edinburgh, United Kingdom
刊名: Gynecologic Oncology, 2018, Vol.150 (2), pp.378-386
来源数据库: Elsevier Journal
DOI: 10.1016/j.ygyno.2018.05.023
关键词: ImmunohistochemistryImmunohistochemistry in gynecological oncologyMolecular pathology in gynecological oncologyReview of immunohistochemistry in gynecological oncologyImmunohistochemical markersMolecular markers
英文摘要: Abstract(#br)Objective(#br)One of the most common challenges in everyday clinical practice of gynecological oncology is to identify the type and the primary origin of a tumor. This is a crucial step in the management, treatment, prognosis, and survival of patients suffering from a gynecological malignancy. Immunohistochemistry has been widely adopted over the last three decades in pathology laboratories all over the world. Recent advances in our understanding of the differentiation of gynecological tumors based on immunohistochemical expression have resulted in use of immunohistochemistry as a major diagnostic tool in gynecology, for precise tumor classification. More recently, advances in molecular pathology, have taken this disease sub-classification further resulting in more effective...
全文获取路径: Elsevier  (合作)
影响因子:3.929 (2012)

  • gynecological 妇科学的
  • oncology 肿瘤学
  • invasive 侵入的
  • diagnosis 特镇述
  • markers 时标
  • pathology 病理学
  • malignant 恶性的
  • molecular 分子的
  • update 修改